Recent study data indicated the use of opioids prior to undergoing reverse shoulder arthroplasty was linked to significantly lower preoperative shoulder function values and worse outcomes than those seen in patients who did not use opioids.
Researchers studied 68 patients from a prospective shoulder arthroplasty registry who underwent reverse shoulder arthroplasty (RSA) to treat rotator cuff arthropathy between 2004 and 2011 at a single institution. Thirty-two patients using opioids preoperatively were compared with 36 patients who did not. Preoperative and final follow-up measurements of shoulder function values and motion measurements were the primary metrics evaluated. Minimum postoperative follow-up was 2 years.